These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 282061)

  • 1. Redistribution of regional blood flow after administration of saralasin in salt-depleted dogs.
    Liang CS; Gavras H; Brunner HR
    Clin Sci Mol Med Suppl; 1978 Dec; 4():243s-246s. PubMed ID: 282061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system inhibition in conscious sodium-depleted dogs. Effects on systemic and coronary hemodynamics.
    Liang CS; Gavras H; Hood WB
    J Clin Invest; 1978 Apr; 61(4):874-83. PubMed ID: 659580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in plasma norepinephrine after intravertebral artery infusion of saralasin in sodium depleted dogs.
    Arita M; Ueno Y; Suruda H; Mohara O; Nishio I; Masuyama Y
    Jpn Circ J; 1983 Mar; 47(3):336-41. PubMed ID: 6339771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-angiotensin system inhibition in conscious dogs during acute hypoxemia. Effects on systemic hemodynamics, regional blood flows, and tissue metabolism.
    Liang CS; Gavras H
    J Clin Invest; 1978 Nov; 62(5):961-70. PubMed ID: 711860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH; Streeten DH; Dalakos TG
    Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.
    MacGregor GA; Dawes PM
    Br J Clin Pharmacol; 1976 Jun; 3(3):483-7. PubMed ID: 973974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin II blockade in the canine puppy under different salt-intake.
    Fiselier TJ; Monnens LA; Lameire NH; van Munster PJ; Peer PG; Leusen IR; Lijnen PJ
    Kidney Int; 1984 Dec; 26(6):823-9. PubMed ID: 6398382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
    Arroyo V; Bosch J; Mauri M; Ribera F; Navarro-López F; Rodés J
    Eur J Clin Invest; 1981 Jun; 11(3):221-9. PubMed ID: 6791942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
    Liebau G; Beyer J; Larbig D; Schick K; Sekanina G; Hayduk K
    Klin Wochenschr; 1977 Jul; 55(13):647-9. PubMed ID: 19645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic and renin-angiotensin system influence on blood pressure and renal blood flow of two-kidney, one clip Goldblatt hypertensive dog.
    Zimmerman BG; Mommsen C; Kraft E
    Hypertension; 1980; 2(1):53-62. PubMed ID: 6989757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular hemodynamics in rats with chronic sodium depletion. Effect of saralasin.
    Steiner RW; Tucker BJ; Blantz RC
    J Clin Invest; 1979 Aug; 64(2):503-12. PubMed ID: 457865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of indomethacin, 6-hydroxydopamine, saralasin, and hemorrhage on renal hemodynamics.
    Fischer R; Ikeda S; Sarma JS; Bing RJ
    J Clin Pharmacol; 1977 Jan; 17(1):5-12. PubMed ID: 833339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of saralasin on blood pressure, renin and renal blood flow in unilateral renovascular hypertension.
    Arlart IP; Rosenthal J; Wagner H; Adam WE; Nobbe F; Franz HE
    Contrib Nephrol; 1978; 11():170-4. PubMed ID: 699587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of angiotensin antagonists on renal vascular resistance and prostaglandin E release.
    Sugawara S; Zimmerman BG
    Clin Exp Hypertens (1978); 1978; 1(1):11-24. PubMed ID: 755643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic response to converting enzyme inhibitor and saralasin in salt-depleted dogs; relation to plasma renin activity [proceedings].
    Conway J; Hatton R; Keddie J
    Br J Pharmacol; 1978 Mar; 62(3):448P. PubMed ID: 205299
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of angiotensin II receptor blockade during exercise: comparison of losartan and saralasin.
    Symons JD; Stebbins CL
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):223-31. PubMed ID: 8856477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of (Sar1, Ala8)-angiotensin II and hypophysectomy on the intestinal resistance vessels and blood pressure following furosemide-induced volume depletion.
    McNeill JR; Wilcox WC; Regnault R
    Can J Physiol Pharmacol; 1976 Jun; 54(3):373-80. PubMed ID: 953866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local control of mesenteric blood flow by the renin-angiotensin system.
    Suvannapura A; Levens NR
    Am J Physiol; 1988 Sep; 255(3 Pt 1):G267-74. PubMed ID: 3421333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic correlates of saralasin-induced arterial pressure changes.
    de Carvalho JG; Dunn FG; Kem DC; Chrysant SG; Froholich ED
    Circulation; 1978 Feb; 57(2):373-8. PubMed ID: 618629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of the competitive angiotensin II antagonist saralasin during the initial phase of glycerol-induced acute renal failure of the rat.
    Greven J; Klein H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):139-43. PubMed ID: 600326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.